EUVIMEDEUVIMED entdecken
Crossref

Metasurface plasmon resonance platform for high-throughput, label-free, real-time, long-term monitoring of in vitro cancer therapy assessment

Wen Li, Mingqian Chen, Youqian Chen, Yihui Yang, Jingyan Ruan, Jiaxiang Chang, Jiacong Li, Gang Logan Liu, Wenjun Hu

Biosensors and Bioelectronics · 2026-01 · 292 · 118052

DOI: 10.1016/j.bios.2025.118052 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2026-01. Verfasst von Wen Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nano Biosensing and Artificial Intelligence, College of Life Science and Technology, State Key Laboratory for Diagnosis and Treatment o…. Hauptthemen laut MEDLINE: Surface Plasmon Resonance, Neoplasms, High-Throughput Screening Assays, Biosensing Techniques. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Fundamental Research Funds for the Central Universities, National Natural Science Foundation of China, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Improving real-time and long-term assessment of cellular behaviors in vitro is crucial for basic scientific research and drug development. This study establishes a high-throughput, real-time, label-free, long-term cell analysis and drug screening platform based on metasurface plasmon resonance (MetaSPR) spectroscopy. This platform was applied to monitor cell proliferation, drug-target cell interactions, cell adhesion, and natural killer cell-mediated cell lysis. The accuracy of the platform was validated by a linear relationship between the MetaSPR results and cell counting kit 8 (CCK-8) assay/imaging signals, providing a solid foundation for further experiments. This platform consistently monitors cell proliferation, drug-target cell interactions, and cell adhesion/spreading, yielding results comparable to those obtained using traditional CCK-8 and flow cytometry methods. Additionally, the cytolytic activity of natural killer cells was evaluated by co-culturing them with target cells at varying effector:target ratios and monitoring their interactions. The results demonstrate that the spectroscopic MetaSPR detection system can quantitatively assess cytolytic activity mediated by immune cells. The rapid response, cost-effectiveness, real-time monitoring capability, and non-invasive characteristics of this platform can enhance the understanding of complex cellular processes and create new possibilities for drug screening and clinical diagnostics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Surface Plasmon ResonanceNeoplasmsHigh-Throughput Screening AssaysBiosensing TechniquesAntineoplastic AgentsHumansKiller Cells, NaturalCell ProliferationCell Line, TumorDrug Screening Assays, AntitumorCell AdhesionEquipment Design

Stichwörter der Autor:innen

Cancer therapy assessmentDrug screeningMetasurface plasmon resonanceReal-time monitoringSensor

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Department of Nano Biosensing and Artificial Intelligence, College of Life Science and Technology, State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Huazhong University of Science…

Förderung

  • Fundamental Research Funds for the Central Universities
  • National Natural Science Foundation of China
  • National Key Research and Development Program of China
  • State Key Laboratory for Diagnosis and Treatment of Infectious Diseases

Zitieren

APA

Li, W., Chen, M., Chen, Y., Yang, Y., Ruan, J., Chang, J., Li, J., Liu, G. L., & Hu, W. (2026). Metasurface plasmon resonance platform for high-throughput, label-free, real-time, long-term monitoring of in vitro cancer therapy assessment. Biosensors and Bioelectronics, 292, 118052. https://doi.org/10.1016/j.bios.2025.118052

Vancouver

Li W, Chen M, Chen Y, Yang Y, Ruan J, Chang J, et al. Metasurface plasmon resonance platform for high-throughput, label-free, real-time, long-term monitoring of in vitro cancer therapy assessment. Biosensors and Bioelectronics. 2026;292:118052. doi:10.1016/j.bios.2025.118052

BibTeX
@article{Li2026,
  author = {Li, Wen and Chen, Mingqian and Chen, Youqian and Yang, Yihui and Ruan, Jingyan and Chang, Jiaxiang and Li, Jiacong and Liu, Gang Logan and Hu, Wenjun},
  title = {Metasurface plasmon resonance platform for high-throughput, label-free, real-time, long-term monitoring of in vitro cancer therapy assessment},
  journal = {Biosensors and Bioelectronics},
  year = {2026},
  volume = {292},
  pages = {118052},
  doi = {10.1016/j.bios.2025.118052}
}
Kostenlos starten →